C. Ormazábal - Concepedia

Author

C. Ormazábal

Universidad de Navarra

Also Known As

C Ormazábal, C. Ormazabal, C. Ormazábal, Cristina Ormazabal, Cristina Ormazábal, Ormazábal C

Publications

659

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Centro de Investigación del Cáncer Universidad de Salamanca Navarre Institute of Health Research Clinica Universidad de Navarra

About

C. Ormazábal is an author at Universidad de Navarra specializing in tumor biology, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	140
2	Cell Biology	4	4	140
3	Pathology	3	3	106
4	Immunology	1	1	34
5	Cancer Genetics	1	1	42

C. Ormazábal

Publications

611

Citations

H-Index

Page 1

	Year	Citations
miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, Molecular Oncology	2014	164
Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis Karmele Valencia, C. Ormazábal, Carolina Zandueta, Clinical Cancer Research	2012	146
Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma Iker Antón, Eva Molina, Diego Luis-Ravelo, American Journal of Respiratory and Critical Care Medicine	2012	56
miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis Karmele Valencia, Marta Martín-Fernández, Carolina Zandueta, Bone Tumor BiologyMir-326 AssociatesBiochemical MarkersMedicinePathology	2012	54
Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis Carolina Zandueta, C. Ormazábal, Naiara Perurena, The Journal of Pathology	2016	50
A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer Diego Luis-Ravelo, Iker Antón, Carolina Zandueta, Oncogene Gene SignatureBone Morphogenic ProteinMedicinePathologyCancer Genomics	2013	42
Transforming and Tumorigenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosine-Kinase Álvaro Cuesta‐Domínguez, Mara Ortega, C. Ormazábal, PLoS ONE ImmunologyCancer BiologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	2012	34
CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2 Paula Aranaz, C. Hurtado, I. Erquiaga, Haematologica	2012	22
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival Cecilia Folio, Marta Zalacaín, Carolina Zandueta, Cancer Biomarkers	2012	21
The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models Marta Martín-Fernández, Karmele Valencia, Carolina Zandueta, Translational Oncology	2017	12

Page 1